Immutable evidence record · ticker

Regeneron Pharmaceuticals, Inc. (REGN34)

Published as observed on 20 August 2026 at 23:41 BST.

Regeneron Pharmaceuticals, Inc. has a positive company news read. Its latest completed weekly trend is negative.

As of
20 Aug 2026, 23:41
Scope
company and instrument
Evidence
14 items
Independent sources
3
Country
Brazil
Sector
Healthcare
Previous read
54.000
Change

Verification

Evidence & related research

This is dated market research. Coverage may be delayed, incomplete or unavailable.

Cite this record:
Sharemaestro, Regeneron Pharmaceuticals, Inc. (REGN34), 2026-08-20, https://sharemaestro.com/evidence/3f97ee39-dfe2-412c-8b01-249654525114/
Record checksum c15b454e30648cd35d376be7ab0a1b1484bc864c242ff50924b233625ef5fe93

Evidence context